Naldini L - Search Results

1

Genetic engineering of hematopoiesis for targeted IFN-α delivery inhibits breast cancer progression.

Escobar G, Moi D, Ranghetti A, Ozkal-Baydin P, Squadrito ML, Kajaste-Rudnitski A, Bondanza A, Gentner B, De Palma M, Mazzieri R, Naldini L. Escobar G, et al. Among authors: naldini l. Sci Transl Med. 2014 Jan 1;6(217):217ra3. doi: 10.1126/scitranslmed.3006353. Sci Transl Med. 2014. PMID: 24382895

2

Transduction of a gene expression cassette using advanced generation lentiviral vectors.

De Palma M, Naldini L. De Palma M, et al. Among authors: naldini l. Methods Enzymol. 2002;346:514-29. doi: 10.1016/s0076-6879(02)46074-0. Methods Enzymol. 2002. PMID: 11883088 No abstract available.

3

Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells.

De Palma M, Venneri MA, Roca C, Naldini L. De Palma M, et al. Among authors: naldini l. Nat Med. 2003 Jun;9(6):789-95. doi: 10.1038/nm871. Epub 2003 May 12. Nat Med. 2003. PMID: 12740570

4

In vivo targeting of tumor endothelial cells by systemic delivery of lentiviral vectors.

De Palma M, Venneri MA, Naldini L. De Palma M, et al. Among authors: naldini l. Hum Gene Ther. 2003 Aug 10;14(12):1193-206. doi: 10.1089/104303403322168028. Hum Gene Ther. 2003. PMID: 12908970

5

Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells.

Biffi A, De Palma M, Quattrini A, Del Carro U, Amadio S, Visigalli I, Sessa M, Fasano S, Brambilla R, Marchesini S, Bordignon C, Naldini L. Biffi A, et al. Among authors: naldini l. J Clin Invest. 2004 Apr;113(8):1118-29. doi: 10.1172/JCI19205. J Clin Invest. 2004. PMID: 15085191 Free PMC article.

6

Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells.

De Palma M, Montini E, Santoni de Sio FR, Benedicenti F, Gentile A, Medico E, Naldini L. De Palma M, et al. Among authors: naldini l. Blood. 2005 Mar 15;105(6):2307-15. doi: 10.1182/blood-2004-03-0798. Epub 2004 Nov 12. Blood. 2005. PMID: 15542582 Free article.

7

Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

De Palma M, Venneri MA, Galli R, Sergi Sergi L, Politi LS, Sampaolesi M, Naldini L. De Palma M, et al. Among authors: naldini l. Cancer Cell. 2005 Sep;8(3):211-26. doi: 10.1016/j.ccr.2005.08.002. Cancer Cell. 2005. PMID: 16169466 Free article.

8

ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially.

Vantaggiato C, Formentini I, Bondanza A, Bonini C, Naldini L, Brambilla R. Vantaggiato C, et al. Among authors: naldini l. J Biol. 2006;5(5):14. doi: 10.1186/jbiol38. J Biol. 2006. PMID: 16805921 Free PMC article.

9

Role of haematopoietic cells and endothelial progenitors in tumour angiogenesis.

De Palma M, Naldini L. De Palma M, et al. Among authors: naldini l. Biochim Biophys Acta. 2006 Aug;1766(1):159-66. doi: 10.1016/j.bbcan.2006.06.003. Epub 2006 Jun 27. Biochim Biophys Acta. 2006. PMID: 16857321 Review.

10

Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer.

Venneri MA, De Palma M, Ponzoni M, Pucci F, Scielzo C, Zonari E, Mazzieri R, Doglioni C, Naldini L. Venneri MA, et al. Among authors: naldini l. Blood. 2007 Jun 15;109(12):5276-85. doi: 10.1182/blood-2006-10-053504. Epub 2007 Feb 27. Blood. 2007. PMID: 17327411 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

311 results

Search Page

Filters